loading
Precedente Chiudi:
$56.09
Aprire:
$56.16
Volume 24 ore:
27,963
Relative Volume:
0.03
Capitalizzazione di mercato:
$5.88B
Reddito:
$628.56M
Utile/perdita netta:
$141.82M
Rapporto P/E:
70.16
EPS:
0.81
Flusso di cassa netto:
$142.60M
1 W Prestazione:
+4.07%
1M Prestazione:
+16.11%
6M Prestazione:
+97.99%
1 anno Prestazione:
+124.31%
Intervallo 1D:
Value
$56.16
$57.22
Intervallo di 1 settimana:
Value
$51.51
$57.22
Portata 52W:
Value
$20.84
$61.66

Corcept Therapeutics Inc Stock (CORT) Company Profile

Name
Nome
Corcept Therapeutics Inc
Name
Telefono
650.688.8803
Name
Indirizzo
101 REDWOOD SHORES PARKWAY, REDWOOD CITY
Name
Dipendente
352
Name
Cinguettio
Name
Prossima data di guadagno
2024-10-30
Name
Ultimi documenti SEC
Name
CORT's Discussions on Twitter

Confronta CORT con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
CORT 56.91 5.88B 628.56M 141.82M 142.60M 0.81
VRTX 449.15 115.74B 10.63B -479.80M -1.35B 13.33
REGN 744.75 81.65B 13.85B 4.65B 3.32B 35.06
ARGX 589.91 34.86B 1.86B -40.29M -1.28B -4.16
ALNY 249.60 32.09B 2.09B -332.26M 16.06M -4.14
BNTX 102.56 24.49B 3.30B -501.07M 1.03B 11.54

Corcept Therapeutics Inc Stock (CORT) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2023-11-06 Aggiornamento Truist Hold → Buy
2023-04-11 Iniziato SVB Securities Market Perform
2023-04-04 Iniziato Piper Sandler Overweight
2023-02-15 Downgrade Jefferies Buy → Hold
2022-08-01 Downgrade Truist Buy → Hold
2022-07-27 Aggiornamento Jefferies Hold → Buy
2022-06-27 Ripresa Canaccord Genuity Buy
2022-02-02 Iniziato Canaccord Genuity Buy
2022-01-28 Iniziato Truist Buy
2020-08-05 Downgrade Jefferies Buy → Hold
2019-09-24 Iniziato Jefferies Buy
2019-09-06 Iniziato H.C. Wainwright Buy
2019-02-04 Downgrade B. Riley FBR Buy → Neutral
2018-08-10 Reiterato Stifel Hold
2018-05-31 Downgrade Stifel Buy → Hold
2018-03-09 Iniziato B. Riley FBR, Inc. Buy
2017-08-31 Iniziato Stifel Buy
2017-02-02 Iniziato Ladenburg Thalmann Buy
2015-04-21 Iniziato FBR Capital Outperform
2014-01-13 Downgrade Stifel Buy → Hold
2013-08-09 Downgrade Janney Buy → Neutral
2013-08-09 Downgrade Ladenburg Thalmann Buy → Neutral
2012-02-21 Reiterato JMP Securities Mkt Outperform
2010-01-06 Aggiornamento Ladenburg Thalmann Neutral → Buy
2008-07-17 Iniziato Rodman & Renshaw Mkt Outperform
2007-06-21 Aggiornamento Punk, Ziegel & Co Mkt Perform → Accumulate
Mostra tutto

Corcept Therapeutics Inc Borsa (CORT) Ultime notizie

pulisher
04:11 AM

Empowered Funds LLC Makes New Investment in Corcept Therapeutics Incorporated (NASDAQ:CORT) - MarketBeat

04:11 AM
pulisher
Nov 20, 2024

Wall Street Analysts Think Corcept (CORT) Could Surge 37.91%: Read This Before Placing a Bet - Yahoo Finance

Nov 20, 2024
pulisher
Nov 20, 2024

Corcept Therapeutics Incorporated (NASDAQ:CORT) Shares Acquired by Connor Clark & Lunn Investment Management Ltd. - MarketBeat

Nov 20, 2024
pulisher
Nov 17, 2024

Cornercap Investment Counsel Inc. Has $426,000 Stock Holdings in Corcept Therapeutics Incorporated (NASDAQ:CORT) - MarketBeat

Nov 17, 2024
pulisher
Nov 16, 2024

Royce & Associates LP Has $16.81 Million Holdings in Corcept Therapeutics Incorporated (NASDAQ:CORT) - MarketBeat

Nov 16, 2024
pulisher
Nov 15, 2024

Teva Defends Mifepristone Antitrust Case Against Corcept - Law360

Nov 15, 2024
pulisher
Nov 15, 2024

Intellectus Partners LLC Purchases Shares of 54,859 Corcept Therapeutics Incorporated (NASDAQ:CORT) - MarketBeat

Nov 15, 2024
pulisher
Nov 15, 2024

Corcept Therapeutics Incorporated (NASDAQ:CORT) Receives $65.25 Average Target Price from Analysts - Defense World

Nov 15, 2024
pulisher
Nov 14, 2024

Corcept Therapeutics director Daniel Swisher sells $131,736 in stock By Investing.com - Investing.com Australia

Nov 14, 2024
pulisher
Nov 14, 2024

Principal Financial Group Inc. Sells 20,770 Shares of Corcept Therapeutics Incorporated (NASDAQ:CORT) - MarketBeat

Nov 14, 2024
pulisher
Nov 13, 2024

Corcept Therapeutics director Daniel Swisher sells $131,736 in stock - Investing.com

Nov 13, 2024
pulisher
Nov 13, 2024

Corcept (CORT) Upgraded to Strong Buy: Here's Why - MSN

Nov 13, 2024
pulisher
Nov 13, 2024

Cushing's Syndrome Market to Show a Rise During the Study Period | - openPR

Nov 13, 2024
pulisher
Nov 13, 2024

Cushing's Syndrome Market Will Drive an Exponential CAGR - openPR

Nov 13, 2024
pulisher
Nov 12, 2024

Corcept Therapeutics Incorporated (NASDAQ:CORT) Given Consensus Recommendation of "Buy" by Brokerages - MarketBeat

Nov 12, 2024
pulisher
Nov 12, 2024

24,800 Shares in Corcept Therapeutics Incorporated (NASDAQ:CORT) Acquired by Versor Investments LP - MarketBeat

Nov 12, 2024
pulisher
Nov 12, 2024

Wealth Enhancement Advisory Services LLC Takes $238,000 Position in Corcept Therapeutics Incorporated (NASDAQ:CORT) - Defense World

Nov 12, 2024
pulisher
Nov 11, 2024

Lisanti Capital Growth LLC Increases Stock Holdings in Corcept Therapeutics Incorporated (NASDAQ:CORT) - MarketBeat

Nov 11, 2024
pulisher
Nov 11, 2024

Zacks Industry Outlook Madrigal, Corcept, Catalyst Larimar And Theravance - Barchart

Nov 11, 2024
pulisher
Nov 11, 2024

Zacks Industry Outlook Madrigal, Corcept, Catalyst Larimar and Theravance - Yahoo Finance

Nov 11, 2024
pulisher
Nov 11, 2024

CWA Asset Management Group LLC Acquires Shares of 20,800 Corcept Therapeutics Incorporated (NASDAQ:CORT) - MarketBeat

Nov 11, 2024
pulisher
Nov 11, 2024

Robeco Institutional Asset Management B.V. Trims Holdings in Corcept Therapeutics Incorporated (NASDAQ:CORT) - MarketBeat

Nov 11, 2024
pulisher
Nov 10, 2024

Corcept Therapeutics Stock Surges 61% in 2024: A Must Buy? - MSN

Nov 10, 2024
pulisher
Nov 09, 2024

Corcept Therapeutics (NASDAQ:CORT) Stock Price Up 8.9%Time to Buy? - MarketBeat

Nov 09, 2024
pulisher
Nov 09, 2024

US Bancorp DE Purchases 12,177 Shares of Corcept Therapeutics Incorporated (NASDAQ:CORT) - MarketBeat

Nov 09, 2024
pulisher
Nov 08, 2024

M&G Plc Buys New Shares in Corcept Therapeutics Incorporated (NASDAQ:CORT) - MarketBeat

Nov 08, 2024
pulisher
Nov 07, 2024

Corcept Therapeutics Incorporated (CORT) Soars to 52-Week High, Time to Cash Out? - MSN

Nov 07, 2024
pulisher
Nov 06, 2024

New York State Teachers Retirement System Sells 17,222 Shares of Corcept Therapeutics Incorporated (NASDAQ:CORT) - MarketBeat

Nov 06, 2024
pulisher
Nov 05, 2024

Corcept Therapeutics' chief development officer sells $489,700 in stock - Investing.com

Nov 05, 2024
pulisher
Nov 05, 2024

Corcept Therapeutics' chief development officer sells $489,700 in stock By Investing.com - Investing.com UK

Nov 05, 2024
pulisher
Nov 05, 2024

Here is Why Growth Investors Should Buy Corcept (CORT) Now - Yahoo Finance

Nov 05, 2024
pulisher
Nov 05, 2024

Corcept Stock At New High; Will The Upcoming Regulatory And Clinical Trial Catalysts Take It Higher? - RTTNews

Nov 05, 2024
pulisher
Nov 05, 2024

Roman Butler Fullerton & Co. Has $261,000 Stock Holdings in Corcept Therapeutics Incorporated (NASDAQ:CORT) - MarketBeat

Nov 05, 2024
pulisher
Nov 05, 2024

Creative Planning Acquires 841 Shares of Corcept Therapeutics Incorporated (NASDAQ:CORT) - Defense World

Nov 05, 2024
pulisher
Nov 04, 2024

Corcept Therapeutics stock soars to all-time high of $50.23 - Investing.com India

Nov 04, 2024
pulisher
Nov 04, 2024

Corcept Therapeutics (NASDAQ:CORT) Sets New 1-Year HighWhat's Next? - MarketBeat

Nov 04, 2024
pulisher
Nov 04, 2024

Corcept Therapeutics stock soars to all-time high of $50.23 By Investing.com - Investing.com Australia

Nov 04, 2024
pulisher
Nov 04, 2024

Wall Street Analysts Believe Corcept (CORT) Could Rally 56.66%: Here's is How to Trade - Yahoo Finance

Nov 04, 2024
pulisher
Nov 04, 2024

Recent Price Trend in Corcept (CORT) is Your Friend, Here's Why - Yahoo Canada Finance

Nov 04, 2024
pulisher
Nov 04, 2024

What is HC Wainwright’s Forecast for CORT FY2024 Earnings? - Defense World

Nov 04, 2024
pulisher
Nov 04, 2024

HC Wainwright Has Bullish Forecast for CORT FY2024 Earnings - MarketBeat

Nov 04, 2024
pulisher
Nov 03, 2024

What is HC Wainwright’s Estimate for CORT FY2026 Earnings? - Defense World

Nov 03, 2024
pulisher
Nov 02, 2024

Corcept Trumps Q3 Earnings & Sales Estimates, Ups '24 Revenue View - MSN

Nov 02, 2024
pulisher
Nov 02, 2024

Corcept Therapeutics (CORT) Stock Declines Amid Market Activity - GuruFocus.com

Nov 02, 2024
pulisher
Nov 01, 2024

Earnings Estimates Moving Higher for Corcept (CORT): Time to Buy? - MSN

Nov 01, 2024
pulisher
Nov 01, 2024

Corcept Therapeutics (NASDAQ:CORT) Stock Price Down 3.2%Here's What Happened - MarketBeat

Nov 01, 2024
pulisher
Nov 01, 2024

FY2026 Earnings Estimate for CORT Issued By HC Wainwright - MarketBeat

Nov 01, 2024
pulisher
Nov 01, 2024

Corcept Therapeutics Incorporated (NASDAQ:CORT) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 01, 2024
pulisher
Nov 01, 2024

Corcept’s relacorilant GRADIENT trial misses primary endpoint - Yahoo Finance

Nov 01, 2024
pulisher
Nov 01, 2024

Corcept Therapeutics Third Quarter 2024 Earnings: Beats Expectations - Yahoo Finance

Nov 01, 2024
pulisher
Oct 31, 2024

Earnings call: Corcept Therapeutics reports robust Q3 growth, raises guidance - Investing.com Canada

Oct 31, 2024

Corcept Therapeutics Inc Azioni (CORT) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$70.68
price down icon 0.42%
$18.62
price up icon 0.16%
$36.06
price down icon 1.68%
$364.60
price up icon 0.01%
$196.58
price up icon 0.88%
$102.64
price up icon 0.27%
Capitalizzazione:     |  Volume (24 ore):